COVID-19 adaptive humoral immunity models: weakly neutralizing versus antibody-disease enhancement scenarios
View ORCID ProfileAntoine Danchin, Oriane Pagani-Azizi, View ORCID ProfileGabriel Turinici, View ORCID ProfileGhozlane Yahiaoui
doi: https://doi.org/10.1101/2020.10.21.20216713
Antoine Danchin
†Institut Cochin, Paris, France
Oriane Pagani-Azizi
‡CEREMADE - ESPCI Paris PSL, Paris, France
Gabriel Turinici
§Université Paris Dauphine - PSL Research University, Paris, France
Ghozlane Yahiaoui
¶Mathematical Institute, University of Oxford, Oxford, United Kingdom

Data Availability
All data is available from public sources.
Posted January 11, 2022.
COVID-19 adaptive humoral immunity models: weakly neutralizing versus antibody-disease enhancement scenarios
Antoine Danchin, Oriane Pagani-Azizi, Gabriel Turinici, Ghozlane Yahiaoui
medRxiv 2020.10.21.20216713; doi: https://doi.org/10.1101/2020.10.21.20216713
Subject Area
Subject Areas
- Addiction Medicine (216)
- Allergy and Immunology (495)
- Anesthesia (106)
- Cardiovascular Medicine (1101)
- Dermatology (141)
- Emergency Medicine (274)
- Epidemiology (9782)
- Gastroenterology (481)
- Genetic and Genomic Medicine (2318)
- Geriatric Medicine (223)
- Health Economics (463)
- Health Informatics (1563)
- Health Policy (737)
- Hematology (238)
- HIV/AIDS (507)
- Medical Education (240)
- Medical Ethics (67)
- Nephrology (258)
- Neurology (2148)
- Nursing (134)
- Nutrition (338)
- Oncology (1183)
- Ophthalmology (366)
- Orthopedics (129)
- Otolaryngology (220)
- Pain Medicine (148)
- Palliative Medicine (50)
- Pathology (313)
- Pediatrics (698)
- Primary Care Research (267)
- Public and Global Health (4673)
- Radiology and Imaging (781)
- Respiratory Medicine (624)
- Rheumatology (274)
- Sports Medicine (210)
- Surgery (252)
- Toxicology (43)
- Transplantation (120)
- Urology (94)